Crescent Capital BDC, Inc.
CCAPNasdaqCIK 1633336OtherFiscal year ends Dec 31
Reports and events: 172 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1020:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342415 |
| 2026-08-1020:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342351 |
| 2026-07-0120:05 ET | 8-K | 8.01 Other events | 0001193125-26-292528 |
| 2026-06-2420:08 ET | 8-K | 2.03 New direct financial obligation | 0001193125-26-281053 |
| 2026-05-2720:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-241887 |
| 2026-05-1821:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-229127 |
| 2026-05-1321:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221986 |
| 2026-05-1321:12 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221936 |
| 2026-05-0820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-214602 |
| 2026-04-0120:15 ET | DEF 14A | Proxy statementPeriod 2026-05-15 | 0001140361-26-012755 |
| 2026-03-0920:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-098526 |
| 2026-02-2521:51 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071922 |
| 2026-02-2519:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-070903 |
| 2025-11-1221:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277614 |
| 2025-11-1221:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277533 |
| 2025-11-0321:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-262594 |
| 2025-08-1320:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108046 |
| 2025-08-1320:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108024 |
| 2025-05-1920:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-122442 |
| 2025-05-1420:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071388 |
| 2025-05-1420:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071368 |
| 2025-04-1520:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-081494 |
| 2025-03-2815:51 ET | DEF 14A | Proxy statementPeriod 2025-05-16 | 0001133228-25-003192 |
| 2025-02-1921:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-023183 |
| 2025-02-1921:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-023153 |
| 2024-12-2322:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-284317 |
| 2024-12-0622:56 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-271710 |
| 2024-11-1211:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124487 |
| 2024-11-1211:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124474 |
| 2024-08-1220:18 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095458 |
| 2024-08-1220:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095420 |
| 2024-06-1720:20 ET | 8-K/A | 7.01 Regulation FD disclosure | 0001193125-24-162625 |
| 2024-06-1110:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-158700 |
| 2024-06-0420:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-154259 |
| 2024-05-1523:57 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-059931 |
| 2024-05-0820:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055659 |
| 2024-05-0820:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055626 |
| 2024-03-2620:42 ET | DEF 14A | Proxy statementPeriod 2024-05-10 | 0001133228-24-002690 |
| 2024-02-2121:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-017941 |
| 2024-02-2121:07 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-017903 |
| 2023-11-0821:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061106 |
| 2023-11-0821:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061089 |
| 2023-08-0920:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040613 |
| 2023-08-0920:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040555 |
| 2023-07-2820:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-197715 |
| 2023-05-1720:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-146997 |
| 2023-05-1020:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-020568 |
| 2023-05-1020:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020540 |
| 2023-03-2820:27 ET | DEF 14A | Proxy statement | 0001133228-23-001600 |
| 2023-03-1511:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-070671 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.